GlassScriptPhysician profile
James Todd Williams
NPI 1376545301
$14,114.32
in general payments reported to CMS, 2019-2025
40 companies · $1,828 in 2025
The $1,828 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,298 · 2020: $1,662 · 2021: $1,899 · 2022: $2,071 · 2023: $2,085 · 2024: $2,273 · 2025: $1,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,032 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,031.55 |
| Education | $153.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,827.26 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $1,711.98 | 2019-2025 | |
| Janssen Biotech, INC. | $1,404.92 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Genzyme Corporation | $1,334.23 | 2019-2025 | |
| Amgen INC. | $725.83 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $622.35 | 2019-2024 | Ilumya |
| Leo Pharma INC. | $560.19 | 2019-2025 | Adbry, Anzupgo |
| Pfizer INC. | $544.37 | 2019-2025 | |
| Ucb, INC. | $529.32 | 2019-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $508.91 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $484.97 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $401.28 | 2019-2025 | Dupixent |
| Incyte Corporation | $371.27 | 2021-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $288.49 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $283.63 | 2019-2025 | Cabtreo |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $185.48 | 2019-2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $175.48 | 2019-2022 | |
| Dermavant Sciences, INC. | $168.99 | 2022-2024 | Vtama |
| Celgene Corporation | $112.84 | 2019 | |
| Organon LLC | $110.21 | 2024-2025 | Vtama |
| Organogenesis INC. | $106.47 | 2021-2025 | Apligraf, Cygnus Dual |
| Kerecis Limited | $98.51 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Genentech USA, INC. | $65.43 | 2019-2022 | |
| Almirall LLC | $56.52 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $51.29 | 2020-2021 | |
| Smith+Nephew, INC. | $39.93 | 2021-2024 | Grafix Pl |
| Journey Medical Corporation | $37.77 | 2022 | |
| Biofrontera INC. | $34.35 | 2022 | |
| Sandoz INC. | $31.13 | 2024 | Hyrimoz |
| Dermira, INC. | $30.79 | 2019 | |
| Convatec INC. | $30.58 | 2023 | |
| Urgo Medical North America, LLC | $26.60 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Hill Dermaceuticals, INC. | $24.88 | 2020-2021 | |
| Epi Health, LLC | $23.57 | 2019 | |
| Botanix Sb INC | $23.34 | 2025 | Sofdra |
| Promius Pharma LLC | $21.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.41 | 2021 | |
| Next Science LLC | $14.65 | 2023 | Blastx, Surgx, Xperience |
| Kowa Pharmaceuticals America, INC. | $13.37 | 2022 | |
| Mission Pharmacal Company | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.